IS8498A - Notkun katepsín K tálma til að meðhöndla alvarlega beintapssjúkdóma - Google Patents
Notkun katepsín K tálma til að meðhöndla alvarlega beintapssjúkdómaInfo
- Publication number
- IS8498A IS8498A IS8498A IS8498A IS8498A IS 8498 A IS8498 A IS 8498A IS 8498 A IS8498 A IS 8498A IS 8498 A IS8498 A IS 8498A IS 8498 A IS8498 A IS 8498A
- Authority
- IS
- Iceland
- Prior art keywords
- cathepsin
- inhibitors
- treatment
- bone loss
- severe bone
- Prior art date
Links
- 206010065687 Bone loss Diseases 0.000 title 1
- 102000004171 Cathepsin K Human genes 0.000 title 1
- 108090000625 Cathepsin K Proteins 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03026430 | 2003-11-19 | ||
| PCT/EP2004/004155 WO2005049028A1 (en) | 2003-11-19 | 2004-04-19 | Use of cathepsin k inhibitors in severe bone loss diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS8498A true IS8498A (is) | 2006-06-06 |
Family
ID=34610055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8498A IS8498A (is) | 2003-11-19 | 2006-06-06 | Notkun katepsín K tálma til að meðhöndla alvarlega beintapssjúkdóma |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070135448A1 (is) |
| EP (1) | EP1686995A1 (is) |
| JP (1) | JP2007511548A (is) |
| KR (1) | KR20060107792A (is) |
| CN (1) | CN1882343A (is) |
| AU (1) | AU2004290874A1 (is) |
| BR (1) | BRPI0416755A (is) |
| CA (1) | CA2545723A1 (is) |
| IL (1) | IL175436A0 (is) |
| IS (1) | IS8498A (is) |
| MA (1) | MA28174A1 (is) |
| MX (1) | MXPA06005635A (is) |
| NO (1) | NO20062870L (is) |
| TN (1) | TNSN06147A1 (is) |
| TW (1) | TW200526198A (is) |
| WO (1) | WO2005049028A1 (is) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0427380D0 (en) * | 2004-12-14 | 2005-01-19 | Novartis Ag | Organic compounds |
| US20080076723A1 (en) * | 2006-09-27 | 2008-03-27 | Sylvan Pharmaceuticals Pty Ltd. | Inhibition of cathepsin K activity and the treatment and prevention of disease |
| EP2117605B1 (en) | 2007-02-28 | 2012-09-26 | Sanofi | Imaging probes |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100518690B1 (ko) * | 1997-11-05 | 2005-10-05 | 노파르티스 아게 | 디펩타이드 니트릴 |
| GB9723407D0 (en) * | 1997-11-05 | 1998-01-07 | Ciba Geigy Ag | Organic compounds |
| JP3892187B2 (ja) * | 1998-11-12 | 2007-03-14 | 生化学工業株式会社 | 環状アミド誘導体 |
| GB0003111D0 (en) * | 2000-02-10 | 2000-03-29 | Novartis Ag | Organic compounds |
| AR036375A1 (es) * | 2001-08-30 | 2004-09-01 | Novartis Ag | Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos |
| US20060281714A1 (en) * | 2003-07-21 | 2006-12-14 | Johann Zimmermann | Combinations of a cathepsin k inhibitor and a bisphosphonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss |
-
2004
- 2004-04-19 WO PCT/EP2004/004155 patent/WO2005049028A1/en not_active Ceased
- 2004-04-19 EP EP04728182A patent/EP1686995A1/en not_active Withdrawn
- 2004-04-19 AU AU2004290874A patent/AU2004290874A1/en not_active Abandoned
- 2004-04-19 CN CNA2004800337541A patent/CN1882343A/zh active Pending
- 2004-04-19 JP JP2006540184A patent/JP2007511548A/ja active Pending
- 2004-04-19 MX MXPA06005635A patent/MXPA06005635A/es not_active Application Discontinuation
- 2004-04-19 US US10/578,167 patent/US20070135448A1/en not_active Abandoned
- 2004-04-19 BR BRPI0416755-4A patent/BRPI0416755A/pt not_active IP Right Cessation
- 2004-04-19 CA CA002545723A patent/CA2545723A1/en not_active Abandoned
- 2004-04-19 KR KR1020067009725A patent/KR20060107792A/ko not_active Withdrawn
- 2004-11-18 TW TW093135477A patent/TW200526198A/zh unknown
-
2006
- 2006-05-04 IL IL175436A patent/IL175436A0/en unknown
- 2006-05-18 TN TNP2006000147A patent/TNSN06147A1/en unknown
- 2006-05-24 MA MA29052A patent/MA28174A1/fr unknown
- 2006-06-06 IS IS8498A patent/IS8498A/is unknown
- 2006-06-19 NO NO20062870A patent/NO20062870L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200526198A (en) | 2005-08-16 |
| CN1882343A (zh) | 2006-12-20 |
| AU2004290874A1 (en) | 2005-06-02 |
| IL175436A0 (en) | 2008-04-13 |
| TNSN06147A1 (en) | 2007-11-15 |
| KR20060107792A (ko) | 2006-10-16 |
| BRPI0416755A (pt) | 2007-02-27 |
| CA2545723A1 (en) | 2005-06-02 |
| JP2007511548A (ja) | 2007-05-10 |
| US20070135448A1 (en) | 2007-06-14 |
| MXPA06005635A (es) | 2006-08-17 |
| WO2005049028A1 (en) | 2005-06-02 |
| MA28174A1 (fr) | 2006-09-01 |
| NO20062870L (no) | 2006-08-18 |
| EP1686995A1 (en) | 2006-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2013022I1 (el) | Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων | |
| DE60322451D1 (de) | 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung | |
| IS7099A (is) | Efnasambönd til að meðhöndla bólgutruflanir | |
| NO20035156D0 (no) | Fremgangsmåter for brönnbehandling | |
| SI1531819T1 (sl) | Uporaba IxB-kinaznih inhibitorjev pri terapiji bolečin | |
| PT1411926E (pt) | Inibidores de integrina para o tratamento de doencas oftalmicas | |
| SI1627639T1 (sl) | Uporaba inhibitorjev COX-2 za zdravljenje afektivnih motenj | |
| CY2018006I2 (el) | Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας | |
| ITMI20031311A0 (it) | Formulazioni per il trattamento di disturbi artrosici | |
| DE502004010131D1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| AU2003297363A1 (en) | Use of cathepsin k inhibitors for the treatment of glaucoma | |
| IL175412A0 (en) | Use of specific histones for the treatment of parasitic diseases | |
| IS7970A (is) | PDE4-hemlar til að meðhöndla eitlafrumuæxli | |
| IS8498A (is) | Notkun katepsín K tálma til að meðhöndla alvarlega beintapssjúkdóma | |
| EP1658274A4 (en) | INHIBITORS OF CATHEPSIN S | |
| NO20054034D0 (no) | Fremgangsmate for behandling av hypotyroidisme. | |
| ATE482707T1 (de) | 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen | |
| GB2410744B (en) | Kinase inhibitors for the treatment of disease | |
| EP1677782A4 (en) | INHIBITORS OF CATHEPSIN S | |
| DK1646387T3 (da) | Anvendelse af indazol-derivater til behandling af neuropatiske smerter | |
| NO20033160D0 (no) | Anordning for behandling av gravann | |
| IS8477A (is) | Beta-laktöm til að meðhöndla MTK sjúkdóma | |
| ITVE20020040A1 (it) | Procedimento di trattamento delle pelli. - | |
| ITMI20022263A1 (it) | Composizioni per il trattamento delle emorroidi. | |
| DK1594498T3 (da) | Anvendelse af etazolat til behandling af sygdomme |